The CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment assesses activities related to HIV, AIDS, and other STDs as carried out by HRSA (Health Resources and Services Administration) and CDC (Centers for Disease Control and Prevention), and makes recommendations for the future directions of their programs to prevent, control, and treat these conditions. View Agenda for May 2012 meeting.
Clinical Guidelines are developed by multiple Federal health agencies to guide providers in delivering HIV/AIDS care in such areas as antiretroviral therapies, opportunistic infections, and HIV testing and counseling.
HIV/AIDS and Incarcerated Individuals in Correctional Settings & the Community
is CDC/HRSA collaboration examining model programs that provide HIV prevention, intervention, and continuity of care within correctional settings. Projects also help recently-released individuals transition back into the community.
HIV/AIDS Data collaboration between HRSA/HAB and CDC occurs on a variety of fronts to collect and analyze HIV/AIDS data. One example is HRSA data provided to CDC on Ryan White grantee and contractor locations and characteristics. CDC also provides HIV/AIDS prevalence data to Part A and Part B areas to assist with grant and formula calculations.
Integrated Guidelines for Developing Epidemiologic Profiles was developed by CDC and HRSA for use in prevention and care planning and working together on developing methods for estimating unmet need.
Survey of HIV Disease and Care is a CDC/HRSA multi-phase cluster sampling method to assess the quality and outcomes of care among HIV-positive people in care.
Across the U.S. Government, many Federal departments are responding to the HIV/AIDS epidemic. Federal domestic HIV/AIDS activities range from prevention, to provision of care and treatment services, to conducting research. Spreading the response to HIV across the Federal Government has helped our response to HIV because each department has its own purpose, expertise, and unique history. The National HIV/AIDS Strategy calls upon Federal departments and agencies to achieve a more coordinated national response to the HIV epidemic in the United States. They are now working to increase the coordination of HIV programs across departmental lines, as well as in enhanced and innovative partnerships with State, territorial, tribal, and local governments. U.S. government agencies have also come together in the common cause of turning the tide against the HIV/AIDS pandemic globally.
This section highlights how Federal departments and agencies are engaged in the response to the HIV/AIDS epidemic. For information about the Federal budget for these activities, visit the How We’re Spending page.
Read about the HIV/AIDS activities of the:
Public Financing and Delivery of HIV/AIDS Care: Securing the Legacy of Ryan White examines HIV care's financing and delivery in light of a changing healthcare system and demographic change in HIV/AIDS cases.
Measuring What Matters is an IOM study examining whether state HIV reporting systems can provide adequate HIV prevalence data to replace AIDS prevalence data in making Ryan White Program formula grants.HIV Integrated Services Project is a developmental effort between HRSA, the Centers for Medicare and Medicaid Services (CMS), and CDC looking at blending federal funding streams to provide more efficient and continuous HIV care.
Integrating HIV Prevention Services Into the Clinical Care Setting of Medicaid and Ryan White CARE Act Programs examines the provision of prevention services to people with HIV under both of these programs.
HIV/AIDS Purchasing Specifications provide sample specifications to address primary and secondary prevention and medical management of HIV/AIDS. They are for use by public sector and private-sector entities.
This HRSA/HAB program addresses the global impact of HIV/AIDS in the areas of care and treatment, including development of sustainable human capacity building models to strengthen quality services in under-served populations.
Impact of Information Technology on Quality of HIV Care is AHRQ- and HRSA- funded grants to study the impact of information technology on health care among medically underserved HIV-infected populations.Minority AIDS Initiative (MAI) is an HHS effort to focus on the disproportionate impact of HIV on minority communities. HRSA and CDC participate on various HHS cross-agency initiatives related to the MAI.
HRSA collaborated with the U.S. Department of Housing and Urban Development to produce a study on integrating substance abuse, mental health and housing for HIV-positive individuals. Housing is Health Care TA Guide, produced in collaboration with HUD/Housing Opportunities for People with AIDS, explains the HIV/AIDS Bureau’s housing policy; provides guidance on its implementation, and includes additional resources on this topic.
On July 13, 2010 the White House released the National HIV/AIDS Strategy (NHAS). This ambitious plan is the nation's first-ever comprehensive coordinated HIV/AIDS roadmap with clear and measurable targets to be achieved by 2015.
Vision for the National HIV/AIDS Strategy
The United States will become a place where new HIV infections are rare and when they do occur, every person regardless of age, gender, race/ethnicity, sexual orientation, gender identity or socio-economic circumstance, will have unfettered access to high quality, life-extending care, free from stigma and discrimination. Both HRSA and CDC encourage coordinated planning.
CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment assesses HRSA and CDC activities related to the HIV, AIDS, and other STDs, and makes recommendations for the future direction of HRSA and CDC programs to prevent, control, and treat STDs, HIV, and AIDS. Engaging People in Care presents results of a HRSA/HAB-sponsored forum where CDC, SAMHSA, NIH, and community/state representatives discussed challenges and opportunities for linking and retaining people with HIV into care. The report also presents recommendations for enhancing outreach-related work.
Advancing HIV Prevention: New Strategies for a Changing Epidemic. Is a CDC initiative with HRSA involvement, whose focus is on reducing barriers to early diagnosis of HIV infection and increasing access to quality medical care, treatment, and ongoing prevention services.
CDC provides funding for HRSA/HAB’s National HIV/AIDS Clinicians’ Consultation Center, specifically its Post Exposure Prophylaxis Line (PEPLine) and Perinatal Hotline.
HRSA/CDC collaboration occurs on multiple SPNS Initiatives, such as: Intervention for SeroPositive IDUs, Research and Evaluation (INSPIRE); HIV/AIDS Demonstration Projects for Incarcerated Individuals within Correctional Settings & the Community; and Prevention for HIV Positive Persons Project.
Ryan White Primary Care Provider Prevention Practices is a HRSA review, with CDC participation, examining prevention practices and policies among Ryan White funded medical providers.
A study of TB practices within Ryan White-funded HIV primary care sites is being conducted by HRSA and CDC to evaluate and improve the level of screening and testing for TB in Part C Ryan White clinics.
Research on Directly Observed Therapy Impact on Treatment Adherence involves CDC and HRSA research on the benefits and risks of directly observed therapy (DOT) in enhancing adherence to HIV medications for PLWH.
Integrated Case Management Project is an effort by HRSA, CDC, SAMHSA, the Department of Justice, and HUD examining case management models and examples of coordinated case management services provided across agencies and payers. Results of the assessment are being used to develop an integrated guidance for use by Federal programs to reduce the possibility of gaps, overlaps and duplication of casement services for agencies serving the needs of those living with HIV.
HIV/AIDS Treatment Adherence Health Outcomes and Cost Study seeks to (1) identify costs associated with providing integrated mental health, substance use, and primary medical treatment to people living with HIV/AIDS; and (2) determine if an integrated approach to care improves treatment adherence, produces better health outcomes, and reduces overall costs associated with HIV treatment.